LinkingMed
PrivateLast Round
Series A
Extension
Oct 30, 2019
Total Funding Raised
$15.31M
Company Overview
LinkingMed operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A Extension round in October 2019.
LinkingMed is an artificial intelligence company that provides a cancer data analysis platform and cloud services for radiotherapy departments and medical centers.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Vertical SaaS, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LinkingMed Comparables
Compare LinkingMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PVmed | 91% | |
| MedMind Technology Co., Ltd. | 89% | |
| Manteia Technologies Co., Ltd. | 88% |
For institutional investors. Book with your work email.
LinkingMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 30, 2019 | ||||
| Series A | May 3, 2018 | ||||
| Early Funding | Jul 5, 2017 | ||||
| Angel | Dec 15, 2016 |
For institutional investors. Book with your work email.
LinkingMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Binhai Venture Capital | Series A Extension |
| Guoke Jiahe Capital | Angel |
| CAS Star | Angel |
| Linear Capital | Series A, Series A Extension, Early Funding |
| Anlong Fund | Angel |
| DHVC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 8, 2025
Grew 50% QoQ, from 6 to 9 employees.
- Jan 24, 2025
Grew 50% QoQ, from 6 to 9 employees.
For institutional investors. Book with your work email.
LinkingMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LinkingMed's valuation, stock price, and market status.
Is LinkingMed a public or private company?
LinkingMed is a private company.
What is the current stock price of LinkingMed?
LinkingMed is a private company, so its shares have no public market price. Caplight tracks LinkingMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LinkingMed worth (valuation)?
Valuation information for LinkingMed is not publicly available.
Can I buy LinkingMed stock?
LinkingMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LinkingMed's last funding round?
LinkingMed's most recent funding round was Series A Extension on October 30, 2019.
Who are the main investors in LinkingMed?
Key investors in LinkingMed include DHVC.
Will LinkingMed IPO soon?
No public IPO plans have been announced for LinkingMed.
How can I track LinkingMed secondary market activity?
Caplight tracks bids, offers, and trades in LinkingMed's shares on secondary markets.